Neuropeptidase Function
Neuropeptidase Function
批准号:
7441311
负责人:
David W Rodgers
金额:
$32.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-15 至 2012-06-30
关键词:
AccountingActive SitesAlzheimer&aposs DiseaseBindingBiologicalBiological AssayBiological ModelsCatalysisCellsCentrifugationCharacteristicsCleaved cellCollectionCommunicationComplexDataDecompression SicknessDepthDiseaseDrug AddictionElectrostaticsEndopeptidasesEnzyme Inhibitor DrugsEnzyme InhibitorsEnzymesGoalsGrantHydrolysisKnowledgeMetalloproteasesModelingMotionMultienzyme ComplexesMutagenesisMutateNervous system structureNeurodegenerative DisordersNeurohormonesNeuromodulatorNeuropeptidesNeurotensinNeurotransmittersNumbersOpioid PeptidePainPatternPeptide ConformationPeptide FragmentsPeptide HydrolasesPeptide LibraryPeptide Signal SequencesPeptidesPlayPropertyProteinsPsychotic DisordersPublic HealthRangeRegulationResearchResolutionRoleSiteSite-Directed MutagenesisSpecificityStructureSubstrate SpecificitySurfaceTestingTherapeuticValidationWorkZincbaseinhibitor/antagonistinterestnervous system disorderneurolysinnovelnovel therapeuticspeptide analogpreferencepreventpuromycin-sensitive aminopeptidasesedimentation velocitytau Proteinstherapeutic targetthimet oligopeptidase
中文摘要
我们的目标是了解底物识别,催化功能和抑制剂的作用。
神经肽酶,使多肽神经递质或神经激素失活或修饰的酶。我们
建议使用两种相关的神经肽酶,神经溶素和硫胺素来研究特异性和功能
寡肽酶作为模型系统。这些锌金属肽酶使神经肽神经降压素失活。
是精神病和疼痛治疗的潜在靶点。他们有一种不同寻常的
由许多神经肽酶共享的性质。他们识别的生物活性多肽上的切割位点
异乎寻常的多样性,没有明显的共同特征。这一不同寻常的属性和其他
将结合高分辨结构探索酶的功能和抑制方面
通过酶的功能研究进行测定。基于之前的工作,我们假设
底物识别主要通过底物多肽的C末端之间的相互作用进行
以及一个不寻常的结合表面,它允许各种不同的多肽构象和结合
联系人。我们还认为,酶的铰链状构象变化伴随着催化。
一种不寻常的抑制剂C28通过阻止这种运动来扰乱酶的功能。四个具体目标
建议:1)测定与多肽及其类似物络合的酶的晶体结构。
为了可视化广泛特异性的结构基础,2)通过以下方式测试和改进我们的识别模型
通过诱变来调节酶的特异性,3)检验所提出的机制
用速度沉降法和其他方法抑制C28的研究4)将我们的研究扩展到嘌呤霉素
敏感的氨基肽酶,以评估识别机制的通用性。
与公共卫生的相关性。这项拟议的研究将提供对酶的了解
参与控制神经系统中细胞之间的通讯。关于这些酶的知识
将使我们能够操纵它们的活动,以治疗神经系统疾病以及其他
疾患
英文摘要
Our goal is to understand substrate recognition, catalytic function, and the action of inhibitors in
neuropeptidases, enzymes that inactivate or modify peptide neurotransmitters or neurohormones. We
propose to study specificity and function using two related neuropeptidases, neurolysin and thimet
oligopeptidase, as model systems. These zinc metallopeptidases inactivate the neuropeptide neurotensin
and are potential therapeutic targets for psychotic disorders and treatment of pain. They have an unusual
property shared by a number of neuropeptidases. The cleavage sites they recognize on bioactive peptides
are unusually diverse, with no apparent common features. The basis for this unusual property and other
aspects of enzyme function and inhibition will be explored by combining high-resolution structure
determination with functional studies of the enzymes. Based on prior work, we hypothesize that broad
substrate recognition occurs primarily through the interaction between the C termini of substrate peptides
and an unusual binding surface, which allows for a variety of different peptide conformations and binding
contacts. We also suggest that a hinge-like conformational change in the enzymes accompanies catalysis
and that an unusual inhibitor, C28, disrupts enzyme function by preventing this motion. Four specific aims
are proposed: 1) to determine crystal structures of enzymes complexed with peptides and peptide analogs in
order to visualize the structural basis for broad specificity, 2) to test and refine our models of recognition by
modulating the specificity of the enzyme through mutagenesis, 3) to examine the proposed mechanism of
C28 inhibition using velocity sedimentation analysis and other assays 4) to extend our studies to puromycin
sensitive aminopeptidase in order to assess the generality of recognition mechanisms.
Relevance to public health. The proposed research will provide an understanding of enzymes that are
involved in controlling communication between cells in the nervous system. Knowledge of these enzymes
will allow us to manipulate their activity in order to treat diseases of the nervous system as well as other
disorders
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cavities in Choline Acetyltransferase and Neuromuscular Disorders
-
批准号:8355348
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2012
-
负责人:David W Rodgers
-
依托单位:
Cavities in Choline Acetyltransferase and Neuromuscular Disorders
-
批准号:8492190
-
项目类别:
-
资助金额:$7.17万
-
财政年份:2012
-
负责人:David W Rodgers
-
依托单位:
PROTEIN ANALYTICAL CORE
-
批准号:8360571
-
项目类别:
-
资助金额:$8.09万
-
财政年份:2011
-
负责人:David W Rodgers
-
依托单位:
PROTEIN ANALYTICAL CORE
-
批准号:8168245
-
项目类别:
-
资助金额:$9.9万
-
财政年份:2010
-
负责人:David W Rodgers
-
依托单位:
KY COBRE: TISSUE CULTURE & PROTEIN PRODUCTION CORE
-
批准号:7960492
-
项目类别:
-
资助金额:$7.95万
-
财政年份:2009
-
负责人:David W Rodgers
-
依托单位:
KY COBRE: TISSUE CULTURE & PROTEIN PRODUCTION CORE
-
批准号:7720897
-
项目类别:
-
资助金额:$8.92万
-
财政年份:2008
-
负责人:David W Rodgers
-
依托单位:
KY COBRE: TISSUE CULTURE & PROTEIN PRODUCTION CORE
-
批准号:7610710
-
项目类别:
-
资助金额:$10.73万
-
财政年份:2007
-
负责人:David W Rodgers
-
依托单位:
KY COBRE: TISSUE CULTURE & PROTEIN PRODUCTION CORE
-
批准号:7382162
-
项目类别:
-
资助金额:$10.76万
-
财政年份:2006
-
负责人:David W Rodgers
-
依托单位:
KY COBRE: TISSUE CULTURE & PROTEIN PRODUCTION CORE
-
批准号:7171387
-
项目类别:
-
资助金额:$15.9万
-
财政年份:2005
-
负责人:David W Rodgers
-
依托单位:
CORE--TISSUE CULTURE & PROTEIN PRODUCTION
-
批准号:6972208
-
项目类别:
-
资助金额:$15.77万
-
财政年份:2004
-
负责人:David W Rodgers
-
依托单位:
Neuropeptidase Function
-
批准号:6395239
-
项目类别:
-
资助金额:$27.84万
-
财政年份:2001
-
负责人:David W Rodgers
-
依托单位:
Neuropeptidase Function
-
批准号:6605827
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2001
-
负责人:David W Rodgers
-
依托单位:
Neuropeptidase Function
-
批准号:6749525
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2001
-
负责人:David W Rodgers
-
依托单位:
Neuropeptidase Function
-
批准号:6540027
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2001
-
负责人:David W Rodgers
-
依托单位:
Protein Core
-
批准号:8751190
-
项目类别:
-
资助金额:$18.81万
-
财政年份:--
-
负责人:David W Rodgers
-
依托单位:
Protein Core
-
批准号:8881236
-
项目类别:
-
资助金额:$18.86万
-
财政年份:--
-
负责人:David W Rodgers
-
依托单位:
Protein Core
-
批准号:9040212
-
项目类别:
-
资助金额:$18.87万
-
财政年份:--
-
负责人:David W Rodgers
-
依托单位:
海外基金